A comparison of the efficacy and safety of loxaglate and lobitridol in renal angioplasty

Dieu, Valérie; Joffre, Francis; Krausé, D.; Bartoli, Jean Michel; Lyonnet, D.; Veyret, C; Garcier, Jean-Marc; Boyer, L.

doi:10.1007/s002709910020

Cited by 5 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous phase-III studies have demonstrated Iobitridol to be a safe and effective contrast agent when used for urography, or regarding the clotting phenomenon when used in renal angioplasty [13,14,15,16,17,18,19,20]. Also in previous works Iobitridol has proved to be safe and well tolerated when compared with Iohexol, as well-known contrast agent with proven efficacy and safety, in phlebography or in contrast-enhanced CT in children [21,22,23,24].…”

Section: Discussionmentioning

confidence: 99%

Hepatic and vascular enhancement at dual-phase helical CT: comparison of Iobitridol 300 and Iohexol 300 in a prospective randomized study

et al. 2001

View full text Add to dashboard Cite

The purpose of this study was to determine hepatic and vascular enhancement, clinical tolerance, and iconographic quality of Iobitridol (300 mg/ml) at dual-phase helical CT and to compare it with Iohexol (300 mg/ml). One hundred forty-six patients were randomly divided into two groups. Each group received 120 ml of Iohexol (group A) or Iobitridol (group B). Mean enhancement of liver, aorta and portal vein was obtained at the arterial phase and at the portal-venous phase. Overall image quality was assessed by two independent blinded investigators. Adverse reactions were recorded. There were no significant differences in demographic characteristics and distribution of patient intrinsic parameters between the two groups, except for blood pressure but without statistical correlation between the difference in blood pressure and the impact on enhancement measurements. There was no significant difference in clinical tolerance and image quality. Mean liver as well as aortic and portal vein enhancement measurements did not show any significant difference. Iobitridol compares favorably with Iohexol. Both products have similar safety, tolerance, and efficacy. Both contrast media have equivalent blood pool concentration and interstitial compartment diffusion.

show abstract

Section: Discussionmentioning

confidence: 99%

Hepatic and vascular enhancement at dual-phase helical CT: comparison of Iobitridol 300 and Iohexol 300 in a prospective randomized study

et al. 2001

View full text Add to dashboard Cite

show abstract

“…In a recent article, 80 mL of gadodiamide was used to guide renal artery stent placement in an 81-year-old patient with a serum creatinine level of 265 mol/L (41). Actually, mean doses of up to about 3 mL/kg of 300 -320 mg I/mL have been used for renal angioplasty in a 70-kg person (42).…”

Section: Discussionmentioning

confidence: 99%

Iodixanol 320 Results in Better Renal Tolerance and Radiodensity than Do Gadolinium-based Contrast Media: Arteriography in Ischemic Porcine Kidneys

Elmståhl¹,

Nyman²,

Leander³

et al. 2008

Radiology

View full text Add to dashboard Cite

show abstract

Current Awareness

2000

Pharmacoepidem. Drug Safe.

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

A comparison of the efficacy and safety of loxaglate and lobitridol in renal angioplasty

Abstract: Regarding the clotting phenomenon, we recorded as many thromboembolic complications with ioxaglate as with iobitridol.

Cited by 5 publications

References 18 publications

Hepatic and vascular enhancement at dual-phase helical CT: comparison of Iobitridol 300 and Iohexol 300 in a prospective randomized study

Hepatic and vascular enhancement at dual-phase helical CT: comparison of Iobitridol 300 and Iohexol 300 in a prospective randomized study

Iodixanol 320 Results in Better Renal Tolerance and Radiodensity than Do Gadolinium-based Contrast Media: Arteriography in Ischemic Porcine Kidneys

Current Awareness

Contact Info

Product

Resources

About